Position in CING
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$135,128 QoQ
Shares Held
23,080
-30.5% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CING Over Time
Shares Held
Position Value (USD)
Derivatives in CING
reported options exposure · as of Jun 30, 2026CallValue
$778,381
CallShares
142,300
PutValue
$1,195,742
PutShares
218,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,280,390 across 349 Biotechnology names. CING ranks #336 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in CING
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,195,742 | 218,600 | Put | Other | 2026-08-14 | |
| 2026-06-30 | $778,381 | 142,300 | Call | Other | 2026-08-14 | |
| 2025-06-30 | $135,128 | 33,201 | Shares | Other | 2025-08-14 | |
| 2021-12-31 | $28,532 | 10,338 | Shares | Defined | 2022-04-05 | |
| No filing history on record for this holder in this stock. | ||||||